Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
Aegis Ventures and Yale Spinout Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine
Yale Spinout Revalia Bio is creating an unprecedented window into how drugs behave in actual human biology